Lv1
30 积分 2025-03-19 加入
Age is no barrier for adults undergoing HCT for AML in CR1: contemporary CIBMTR analysis
4天前
已完结
老年急性髓系白血病的治疗
4天前
已完结
Venetoclax Has Potent Efficacy in NPM1 mutated AML with Acquired Resistance Associated with Either Perturbed Pro-Survival Signalling or NPM1 wild-Type Populations
5天前
已关闭
Venetoclax plus ‘2 + 5’ modified intensive chemotherapy with daunorubicin and cytarabine in fit elderly patients with untreated de novo acute myeloid leukaemia: a single‐centre retrospective analysis
8天前
已完结
Choosing between intensive and less intensive front-line treatment approaches for older patients with newly diagnosed acute myeloid leukaemia
12天前
已完结
The rare IRF2BP2-RARA fusion in acute promyelocytic leukemia
1个月前
已完结
Causes of death and treatment-related mortality in newly diagnosed childhood acute lymphoblastic leukemia treatment with Chinese Children’s Cancer Group study ALL-2015
1个月前
已完结
Secular trend in disease burden of leukemia and its subtypes in China from 1990 to 2019 and its projection in 25 years
1个月前
已完结
A novel subclonal rearrangement of the STRN3::PDGFRB gene in de novo acute myeloid leukemia with NPM1 mutation and its leukemogenic effects
1个月前
已完结
皖公网安备34019202002308
